Insiders Trades

★ Sign in to follow

RA

Robert Abenante

Abattis Bioceuticals Corp.

Cumul. flow

Total declarations

15

Company

1

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 10 Aug 2018 for Abattis Bioceuticals Corp., €445k.

Insider track record

Disclosed buys

0

Disclosed sells

0

Signal history

Robert Abenante: trading record in brief

Robert Abenante is a declared insider of Abattis Bioceuticals Corp., with filings sourced from SEDI. We count 15 filings; the first trade dates from 10 April 2017 and the latest from 18 June 2018.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 10 August 2018: a transaction of €445k, in Abattis Bioceuticals Corp. Typically, a trade is published a median of 4 days after it takes place. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.

Companies and markets linked to Robert Abenante

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Abattis Bioceuticals Corp. (CA)

Declarations15 total

●

Robert Abenante

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives18 Jun 2018Abattis Bioceuticals Corp.

684,337 CAD13SEDI

4,677,625 shares@ CA$0.146320.8% of flowCommon SharesTSXSEDI:3221446

◆

Robert Abenante

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives12 Mar 2018Abattis Bioceuticals Corp.

810,000 CAD13SEDI

3,000,000 shares@ CA$0.2724.0% of flowCommon SharesTSXSEDI:3152260

◆

Robert Abenante

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives13 Feb 2018Abattis Bioceuticals Corp.

2M CAD16SEDI

6,500,000 shares@ CA$0.262551.5% of flowCommon SharesTSXSEDI:3133051

◆

Robert Abenante

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives18 Dec 2017Abattis Bioceuticals Corp.

15,350 CAD11SEDI

35,698 shares@ CA$0.430.5% of flowCommon SharesTSXSEDI:3102275

●

Robert Abenante

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives3 Oct 2017Abattis Bioceuticals Corp.

0SEDI

27,586 sharesCommon SharesTSXSEDI:3076728

◆

Robert Abenante

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives30 Oct 2017Abattis Bioceuticals Corp.

7,789 CAD11SEDI

56,116 shares@ CA$0.13880.2% of flowCommon SharesTSXSEDI:3076729

◆

Robert Abenante

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives8 Sept 2017Abattis Bioceuticals Corp.

15,757 CAD11SEDI

144,827 shares@ CA$0.10880.5% of flowCommon SharesTSXSEDI:3057411

◆

Robert Abenante

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives21 Aug 2017Abattis Bioceuticals Corp.

13,358 CAD11SEDI

154,968 shares@ CA$0.08620.4% of flowCommon SharesTSXSEDI:3049953

◆

Robert Abenante

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives12 Jul 2017Abattis Bioceuticals Corp.

13,506 CAD11SEDI

124,137 shares@ CA$0.10880.4% of flowCommon SharesTSXSEDI:3036920

◆

Robert Abenante

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives12 Jul 2017Abattis Bioceuticals Corp.

72,500 CAD11SEDI

500,000 shares@ CA$0.1452.2% of flowCommon SharesTSXSEDI:3036921

◆

Robert Abenante

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives12 Jun 2017Abattis Bioceuticals Corp.

92,500 CAD19SEDI

500,000 shares@ CA$0.18577.9% of flowCommon SharesTSXSEDI:3021768

◆

Robert Abenante

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives12 Jun 2017Abattis Bioceuticals Corp.

10,443 CAD12SEDI

75,675 shares@ CA$0.1388.8% of flowCommon SharesTSXSEDI:3021767

◆

Robert Abenante

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives28 Apr 2017Abattis Bioceuticals Corp.

15,750 CAD12SEDI

87,500 shares@ CA$0.1813.3% of flowCommon SharesTSXSEDI:3017926

●

Robert Abenante

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives10 Apr 2017Abattis Bioceuticals Corp.

0SEDI

Common SharesTSXSEDI:2999750

◆

Robert Abenante

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives20 Apr 2017Abattis Bioceuticals Corp.

0SEDI

339,362 sharesCommon SharesTSXSEDI:2999751

15 of 15 declarations